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BACKGROUND: Cyenopyrafen is an inhibitor of complex II of the mitochondrial 
electron transport chain. It has a molecular structure that shares some common features 
with frequently used complex I inhibitors such as pyridaben. To evaluate whether this 
similarity in structure poses a cross-resistance risk that might complicate resistance 
management, we selected for pyridaben and cyenopyrafen resistance in the laboratory 
and characterized resistance. 
RESULTS: The selection for cyenopyrafen conferred cross-resistance to pyridaben 
and vice versa. Resistance towards these both acaricides was incompletely dominant in 
adult females. However, in eggs maternal effects were observed in pyridaben 
resistance, but not in the cyenopyrafen-resistance (completely dominant). In the 
cyenopyrafen resistant strain, the LC50 of eggs remained lower than the commercially 
recommended concentration. The common detoxification mechanisms by cytochrome 
P450 was involved in resistance to these acaricides. Carboxyl esterases were also 
involved in cyenopyrafen resistance as a major factor. 
CONCLUSIONS: Although cross-resistance suggests that pyridaben resistance would 
confer cyenopyrafen cross-resistance, susceptibility in eggs functions to delay the 
development of cyenopyrafen resistance.  
 




1   INTRODUCTION
The twospotted spider mite Tetranychus urticae Koch is an economically important pest 1 
in many agricultural crops, since it rapidly develops resistance to newly developed 2 
acaricides. Spider mite control and resistance management has become complicated due 3 
to cross-resistance that is often observed among acaricides with similar mode of action 4 




Cyenopyrafen is a mitochondrial complex II electron transport inhibitor that was 7 
commercialized in 2009.
3–6
 To the best of our knowledge, cyenopyrafen resistance in T. 8 
urticae has not been reported. On the other hand, mitochondrial complex I electron 9 
transport inhibitors (complex I inhibitors) including pyridaben, tebufenpyrad, and 10 
fenpyroximate were commercialized in the early 1990s and have ever since been 11 
frequently used worldwide. Although the target sites are distinctive, cyenopyrafen is 12 
composed of a molecular structure common to complex I inhibitors: one pyrazole ring 13 
and one tertiary butyl group.  14 
Cross-resistance among complex I inhibitors had been reported in several previous 15 
studies.
7–10
 Stumpf and Nauen
10 
pointed out that common molecular structures among the 16 
complex I inhibitors, specifically heterocyclic rings with two nitrogen atoms associated 17 
with long hydrophobic tail structures with at least one tertiary butyl group, are a possible 18 
cross-resistance factor. The synergism of piperonyl butoxide (PBO) on toxicity, together 19 
with the documentation of increased cytochrome P450 activity, suggest that metabolism 20 
by cytochrome P450 is one of the major (cross-)resistance mechanism to complex I 21 
inhibitors in T. urticae.
7
 Therefore, the question whether the similarity in structure 22 
between cyenopyrafen and the complex I inhibitors would also result in cross-resistance 23 
 4 
 
is the objective of this study.  24 
We tested whether cross-resistance would occur between cyenopyrafen and 25 
pyridaben. First, we selected a field collected T. urticae population with both acaricides 26 
separately, and tested whether selection by cyenopyrafen causes loss of susceptibility to 27 
pyridaben or vice versa. Then, we investigated the mode of inheritance of resistance, and 28 
tested the synergetic effects of detoxification enzyme inhibitors. From these results, we 29 
discuss the mechanisms of cross-resistance and the associated risks in mite management.  30 
 31 
2   MATERIALS AND METHODS 32 
2.1   Chemicals 33 
The acaricides used in this study were commercial formulations of cyenopyrafen 34 
(Starmite,® 30 SC) and pyridaben (Sanmite, ® 20 SC). Chemicals were suspended in 35 
appropriate volumes of distilled water.  36 
Synergists used to evaluate the role of detoxification enzymes were PBO (90%; a 37 
cytochrome P450s inhibitor), S-benzyl-O,O-diisopropyl phosphorothioate (IBP, 98%; a 38 
carboxyl esterase inhibitor), triphenyl phosphate (TPP, 97%; a carboxyl esterase 39 
inhibitor), and diethylmaleate (DEM, 97%; glutathione S-transferase inhibitor). All these 40 
synergists were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). 41 
 42 
2.2   Mites 43 
A field population (NO) of T. urticae was originally collected from roses in a greenhouse 44 
in Heguri, Nara Prefecture, Japan (34°37′N, 135°42′E), in May 2010. The mites on the 45 
roses had been sprayed mainly with dienochlor and occasionally with etoxazole, 46 
hexythiazox, chlorfenapyr, acequinocyl, bifenazate, emamectin benzoate, or milbemectin. 47 
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On the other hand, cyenopyrafen, pyridaben, and cyflumetofen had never been used 48 
before May 2010. 49 
An acaricide susceptible strain (NS) had been originally collected from 50 
chrysanthemum (Chrysanthemum morifolium R.) in Katsuragi, Nara Prefecture, Japan 51 
(34°30´N, 135°43´E) in 1998. NS was established as a susceptible strain after adversely 52 
selecting for increased susceptibility to both etoxazole and hexythiazox in a laboratory by 53 
Asahara et al.
11
 and then reared under acaricide-free conditions until this study.  54 
All strains and stock cultures were reared on detached kidney bean (Phaseolus 55 
vulgaris L.) leaves placed on water-soaked cotton in Petri dishes (9 cm diameter), in the 56 
laboratory at 25°C, 60 % relative humidity, and 16:8 h light and dark photoperiod. 57 
 58 
2.3   Laboratory selections and cross-resistance 59 
Laboratory selection with cyenopyrafen and pyridaben was performed separately to 60 
obtain resistant strains (R) to each acaricide and to evaluate the effects of selection by 61 
one acaricide on the susceptibility to the other acaricide (cross-resistance). Prior to 62 
selection, we prepared two subpopulations derived from the NO culture. Then, one 63 
subpopulation was selected with cyenopyrafen six times, and the other was exposed to 64 
pyridaben five times. The concentration of acaricides applied to each selection was 65 
gradually increased with progression of the selection, i.e., in the order of 75, 150, 1000, 66 
1500, 1500, and 1500 mg/L for cyenopyrafen, and 200, 1000, 10000, 10000, and 10000 67 
mg/L for pyridaben. 68 
Five fresh kidney bean leaf discs, each containing more than 200 mites of various 69 
developmental stages, were separately dipped into acaricide solution for 10 s, dried on a 70 
paper towel at room temperature, and then replaced on water-soaked cotton in Petri 71 
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dishes. Five days later, adult females that survived on acaricide-treated leaf discs were 72 
moved to newly prepared kidney bean leaf discs with a fine brush and the population was 73 
allowed to increase. The subsequent selections were performed at 14–day intervals. The 74 
strains obtained after the selection with cyenopyrafen (NCR) and pyridaben (NPR) were 75 
separately reared on kidney bean leaf discs (~5 cm in diameter) without additional 76 
selections. 77 
 78 
2.4   Toxicological tests 79 
2.4.1 Ovicidal bioassay 80 
Ten adult females were introduced to a kidney bean leaf disc prepared as described above 81 
and were allowed to oviposit under laboratory conditions. After 24 h the females were 82 
removed from the leaf disc. Then, the leaf disc with eggs was dipped into acaricide 83 
solution for 10 s. After being dried on a paper towel at room temperature, the leaf disc 84 
was replaced on water-soaked cotton in the Petri dish. Mortality was calculated 7 days 85 
after acaricide treatment by counting the number of unhatched eggs.  86 
Approximately 60–100 eggs were present per leaf disc. Three leaf discs were used 87 
per concentration for each strain and acaricide. The data of the three leaf discs were 88 
pooled and analyzed as a no replication experiment. Mortality rates were corrected using 89 
Abott’s formula.12 The results were analyzed by probit regressions to determine the 50% 90 
lethal concentration (LC50) values and 95% fiducial limits that were calculated using a 91 
program for the 50% effective dose (ED50; http://aoki2.si.gunma-u.ac.jp/R/ed50.html) by 92 
Aoki
13
 with some modifications using R software.
14
 Resistance factors (RFs) were 93 
calculated by dividing the LC50 value for each selected strain (NCR or NPR) by the LC50 94 




2.4.2 Adultcidal bioassays 97 
Ten adult females were moved from mite culture to a kidney bean leaf disc (2 × 2 cm) 98 
and allowed to settle for 30 min. The leaf disc with adult females was dipped into 99 
acaricide solution for 10 s, dried on a paper towel at room temperature, and then replaced 100 
on water-soaked cotton in a Petri dish. Distilled water without acaricide was used as 101 
control. The number of survivors was counted under a binocular microscope 5 days after 102 
the acaricide treatment. Mites that could move normally were scored as alive while mites 103 
that were paralyzed after touching with a fine brush were scored as dead. Individuals that 104 
escaped from leaf discs were excluded from data analyses. 105 
Six leaf discs were used per concentration for each strain and acaricide. The data of 106 
the six leaf discs were pooled and analyzed as a no replication experiment. These results 107 
were analyzed in the same way as described for the ovicidal bioassay. 108 
 109 
2.5   Crosses to determine the mode of inheritance 110 
To test dominance and maternal effects of resistance, the resistant strain (NCR or NPR) 111 
was reciprocally crossed with the susceptible strain (NS). Then, a toxicological test was 112 
applied to eggs and females of the parental strains and F1 generations derived from the 113 
reciprocal crosses. 114 
Sixty teleiochrysalid females of one strain and 60 adult males of the other strain 115 
were randomly chosen from each culture and introduced to a fresh kidney bean leaf disc 116 
using a fine brush. Females were usually inseminated immediately following their last 117 
molt. After 3 days, to obtain F1 eggs, the crossed females were transferred onto a new 118 
leaf disc and allowed to oviposit for 24 h under laboratory conditions. Cyenopyrafen and 119 
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pyridaben susceptibility of the F1 eggs was evaluated by the ovicidal bioassay.  120 
To obtain hybrid F1 females, the crossed females described above were moved to a 121 
new leaf disc. After 24 h, the parental females were removed, and F1 eggs laid on the leaf 122 
disc were reared to adulthood. Cyenopyrafen and pyridaben susceptibility of the F1 adult 123 
females was evaluated by the adulticidal bioassay.  124 











where X is the logarithmic LC50 value of the resistant strain, and Y and Z are the LC50 127 
values of F1 females and the susceptible strain, respectively. The D values should range 128 
from −1 (resistance inherits completely recessive) to 1 (completely dominant).15 Because 129 
of arrhenotokous parthenogenesis in T. urticae, F1 eggs produced from R♀ × S♂ and S♀ 130 
× R♂ crosses should contain resistant and susceptible male eggs, respectively. Therefore, 131 
the LC50 values were not determined for the F1 eggs. 132 
 133 
2.6. Synergism tests 134 
Synergists were dissolved in aqueous acetone (1:1) and sprayed on a leaf disc (2 cm in 135 
diameter) containing 10 adult females using a glass chromatograph sprayer (0.3 mL per 136 
leaf disc). After 4 h of synergist treatment, the females were applied to the adulticidal 137 
bioassay, and their LC50 value was determined. To minimize the effects of the synergist 138 
itself, the concentrations of synergists used for the treatments were settled lower than the 139 
LC10 of NS at 250, 100, 250, and 500 mg/L for PBO, IBP, TPP, and DEM, respectively, 140 
based on preliminary experiments. 141 
The synergistic ratio (SR) was calculated by dividing the LC50 value without the 142 
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synergist by the LC50 value with the synergist. If the 95% confidence limits of the LC50 143 
values did not overlap between without and with the synergist, then the synergistic effect 144 
was considered to be significant. 145 
 146 
3. Results 147 
3.1. Laboratory selections and cross resistance  148 
LC50 values of NS were below 1 and 4 mg L
−1
 in eggs and adult females, 149 
respectively, for both cyenopyrafen and pyridaben (Table 1). A moderate degradation of 150 
cyenopyrafen susceptibility had been occurred in NO (LC50 values and RFs were 59.34 151 
mg L
−1
 and 24.52, respectively, in adult females and 35 mg L
−1
 and 140, respectively, in 152 
eggs). In contrast, no decrease in LC50 toward pyridaben was found in NO. However, the 153 
slopes of the pyridaben concentration–mortality regression lines in adult females were 154 
smaller in NO than NS (Table 1). Moreover, the mortality from 10000 mg L
−1
 pyridaben 155 
in adult females of NO calculated from the concentration–mortality regression line was 156 
74.1%, indicating the heterogeneity of NO in pyridaben resistance.  157 
Senior author (MO) with a colleague tentatively studied acaricide susceptibility of T. 158 
urticae population collected from the same greenhouse in June 2009 (only four months 159 
after commercialization of cyenopyrafen in Japan). They found survivability more than 160 
80% in adult females after application of cyenopyrafen to adult females at the 161 
concentration of 150 mg L
-1
, although all eggs died (Uesugi and Osakabe unpublished 162 
data). Moreover, serious or moderate degradation of efficacy was also found in 163 
cyflumetofen, bifenazate, acequinocyl, milbemectin, and tetradifon in 2009 (Uesugi and 164 
Osakabe unpublished data), suggesting the potential development of multiple resistances in 165 
NO. The moderate degradation of cyenopyrafen susceptibility and the heterogeneity of 166 
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pyridaben susceptibility in NO were also potentially caused by the multiple resistances. 167 
After laboratory selection with cyenopyrafen (NCR), the LC50 for cyenopyrafen 168 
reached 103.68 and 1502.82 mg L
−1
 (RF = 414.72 and 621; 3- and 25-fold of NO) in 169 
eggs and adult females, respectively (Table 1). LC50 of NCR for pyridaben also increased 170 
to 1454.98 and >10000 mg L
−1
 (RF = 1914.45 and >2583.98) in eggs and adult females, 171 
respectively. However, the slope of the pyridaben concentration–mortality regression 172 
lines for NCR (0.40 in eggs and 0.24 in adult females) were smaller than that of NS 173 
(Table 1). Moreover, the mortality of 10000 mg L
−1
 pyridaben calculated from the 174 
concentration mortality regression line was 34.6% and 63.1% for the adult females and 175 
eggs of NCR, respectively. This result indicates the locus (or loci) involved with 176 
pyridaben resistance might remain heterogeneous in NCR. 177 
For NPR, the LC50 of both eggs and adult females exceeded 10000 mg L
−1
 for 178 
pyridaben; mortality was 3.4% at 10000 mg L
−1
 (n = 59, corrected mortality = 0%; 179 
mortality of control = 3.4%, n = 58). Therefore, calculating LC50 and obtaining a formula 180 
for concentration–mortality regression lines were impossible. The LC50 values of NPR 181 
eggs and adult females for cyenopyrafen increased to 74.16 and 430.99 mg L
−1
 (RF = 182 
296.64 and 178.10), respectively.  183 
 184 
3.2   Mode of inheritance 185 
3.2.1 Eggs 186 
For cyenopyrafen, the mortality–concentration regression lines of F1 eggs produced 187 
by NCR♀ × NS♂ were close to that of NCR (Fig. 1a). In F1 eggs from NS♀ × NCR♂, a 188 
part of the eggs showed a mortality rate similar to that of NS, whereas the remaining 189 
eggs showed mortality similar to NCR. This division was rational because of 190 
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arrhenotokous parthenogenesis in this mite; haploid male eggs produced by NS♀ should 191 
be cyenopyrafen-susceptible. Therefore, cyenopyrafen resistance in the eggs was 192 
determined to be completely dominant. 193 
We could not represent the plots of mortality for pyridaben or the 194 
mortality–concentration regression line for NPR because LC50 was too high. Mortality of 195 
F1 eggs from NS♀ × NPR♂ plotted near the mortality–concentration regression line for 196 
NS (Fig. 1b). In contrast, F1 eggs produced by NPR♀ × NS♂ showed obviously higher 197 
tolerance.  198 
To confirm the reproductive compatibility between NPR and NS, we additionally 199 
performed intra- and inter-strain crosses. We placed 60 teleiochrysalid females and 30 200 
adult males together on a leaf disk for three days. Then, 20 adult females (randomly 201 
chosen from the emerged adult females) were allowed to oviposit for one day. Oviposited 202 
eggs were reared until adulthood, and sex ratios were checked under a binocular 203 
microscope. As a result, we obtained similar sex ratios from all reciprocal crosses 204 
(NPR♀ × NPR♂: 241 eggs, development = 93.8%, sex ratio (females/total) = 0.74; 205 
NPR♀ × NS♂: 248, 93.5%, 0.75; NS♀ × NPR♂: 191, 93.2%, 0.72; NS♀ × NS♂: 175, 206 
89.1%, 0.75), indicating that no reproductive incompatibility was involved in the results 207 
of crosses between these strains. Therefore, we consider that some maternal factors play 208 
a role in pyridaben resistance. 209 
 210 
3.2.2 Adult females 211 
The mortality–concentration regression lines of cyenopyrafen for F1 females from both 212 
NCR♀ × NS♂ and NS♀ × NCR♂ appeared closely to NCR (Fig. 2a). The LC50 values 213 
corresponded to each other between the reciprocal crosses, and the degree of dominance 214 
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of resistance (D) was 0.47 and 0.50 in F1 females from NCR♀ × NS♂ and NS♀ × NCR♂, 215 
respectively (Table 2). Therefore, the inheritance of cyenopyrafen resistance in adult 216 
females was estimated to be incompletely dominant.  217 
For pyridaben, the LC50 values of F1 females from the reciprocal crosses were 218 
obviously higher than those of NS (Table 2, Fig. 2b), suggesting that pyridaben resistance 219 
was incompletely dominant.  220 
 221 
3.3   Synergism test 222 
Pretreatment of PBO and TPP resulted in high synergistic effects on cyenopyrafen 223 
toxicity in the NCR strain. The LC50 of NCR for cyenopyrafen (1502.82 mg L
−1
) was 224 
reduced to 18.74 and 22.01 mg L
−1
 by PBO and TPP (SR = 80.19 and 68.28), 225 
respectively (Table 3). Lesser but significant synergistic effects were exhibited with IBP 226 
and DEM, and LC50 values were reduced to 734.15 and 551.25 mg L
−1
 (SR = 2.05 and 227 
2.73), respectively. This suggests that cyenopyrafen resistance in NCR is mainly linked 228 
with enhanced metabolism by cytochrome P450s and carboxyl esterases. Other carboxyl 229 
esterases inhibited by IBP and glutathione S-transferases are also potentially involved 230 
with the cyenopyrafen resistance of NCR as minor factors. 231 
In the NPR strain, a clear synergistic effect was shown only when pretreated with 232 
PBO. The LC50 of NPR for pyridaben (>10000 mg L
−1
) was reduced to 73.24 mg L
−1
 (SR 233 
> 136.54). No synergistic effects were observed from TPP, IBP and DEM treatments. 234 
Therefore, one of the main mechanisms of pyridaben resistance in NPR is detoxification 235 
by cytochrome P450s.  236 
 237 
4   Discussion 238 
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The LC50 value of cyenopyrafen was rapidly increased by a limited number of laboratory 239 
selections. The RFs increased to 25-fold in adult females and 3-fold in eggs, respectively, 240 
in comparison with the field collected parental population (NO). The mode of inheritance 241 
is incompletely (adult females) or completely (eggs) dominant, which potentially 242 
accelerate resistance development in general.
16
 Reciprocal crossing revealed no maternal 243 
inheritance of cyenopyrafen resistance, indicating no involvement of genetic 244 
modification in the mitochondrial DNA. Also, there are no subunits of complex II 245 
encoded by the mitochondrial DNA.  246 
Cyenopyrafen is pro-acaricide activated after hydrolysis by esterases
5
 similar to 247 
cyflumetofen, another complex II inhibitor
 17
, and also bifenazate, a complex III 248 
inhibitor.
18,19
 Indeed, slight increase of LC50 values was observed in NS treated with IBP 249 
and TPP. However, the effects of the esterase inhibitors were very small in comparison 250 
with the case of bifenazate when esterases were inhibited with another chemical, 251 
S,S,S-tributyl-phosphorotrithioate (DEF).
18
 Esterases which activate cyenopyrafen might 252 
be less sensitive to IBP and TPP, as it has been shown that the level of esterase inhibition 253 
defers between inhibitors in T. urticae.
19
 In contrast, pretreatment by TPP decreased LC50 254 
of NCR to the concentration lower than the LC50 before laboratory selection (NO) as well 255 
as that by PBO. Pretreatment by IBP also halved the LC50 of NCR toward cyenopyrafen. 256 
Therefore, both cytochrome P450 and carboxyl esterases are essential for the 257 
detoxification of cyenopyrafen. On the other hand, a significant synergistic effect was 258 
obtained by PBO pretreatment, but the pretreatments with TPP, IBP, and DEM did not 259 
exert any influence toward pyridaben resistance levels in NPR. Synergism by PBO was 260 
commonly observed among the studies associated with the complex I inhibitors.
7,8,10,20
 261 
Our study suggests that the common molecular structures among the complex I inhibitors 262 
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are also a possible cross-resistance factor between pyridaben (or other complex I 263 
inhibitors) and cyenopyrafen, but unique mechanisms by carboxyl esterases are also 264 
involved with cyenopyrafen resistance. 265 
These results suggest that an application history of pyridaben or other complex I 266 
inhibitors could potentially confer cyenopyrafen cross-resistance. However, although the 267 
LC50 values of adult females were significantly higher than the commercially 268 
recommended concentration of cyenopyrafen (150 mg L
−1
) in both NCR and NPR, the 269 
LC50 values of those eggs toward cyenopyrafen still remained lower than the 270 
commercially recommended concentration. Therefore, application with cyenopyrafen at 271 
the commercially recommended concentration can be expected to cause significant 272 
mortality of eggs even after achieving some resistance levels in adult females.  273 
A similar age-dependent expression of resistance (lower resistance levels in eggs) 274 
has been recently reported in the resistance of T. urticae
21
 and the European red mite 275 
Panonychus ulmi Koch
22
 against spirodiclofen, which is an acaricide that interfere with 276 
lipid biosynthesis (expected acetyl-CoA carboxylase inhibitor).
23
 Cytochrome P450 and 277 
carboxyl esterase in T. urticae and only cytochrome P450 in P. ulmi were involved in the 278 
detoxification process of spirodiclofen, respectively.
21,22
 Demaeght et al.
24
 revealed that 279 
the expression levels of CYP392E10, that metabolizes spirodiclofen, were very low in 280 
eggs compared to other life stages in T. urticae. Therefore, it would be interesting to 281 
investigate whether the expression levels of the cyenopyrafen resistance related 282 
cytochrome P450 gene are also low in eggs of the NCR strain. 283 
In this study, we transferred adult females survived the selection with acaricides to 284 
new leaf discs and allowed the mites to increase without additional chemical application, 285 
resulting quick development of cyenopyrafen resistance in NCR. However, the 286 
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susceptibility in eggs to cyenopyrafen is most likely to cause more effective decrease in 287 
the population sizes than the effects expected from the resistance levels of adult females. 288 
In a theoretical study, a higher degree of reduction delays the population increase and 289 
thus delays resistance development.
16
 This might be true in T. urticae populations which 290 
have acquired resistance to pyridaben or other complex I inhibitors. Moreover, we found 291 
that carboxyl esterase inhibited by TPP were also essential for cyenopyrafen resistance, 292 
and that inhibited by IBP and glutathione S-transferase might partially contribute to 293 
expression of the resistance. Such resistance mechanisms were not likely to be selected 294 
by the application with pyridaben. Although significance of carboxyl esterase inhibited 295 
by DEF in pyridaben resistance had been reported by Van Pottelberge et al.
7
, 296 
pretreatments with TPP and IBP had no effects on pyridaben resistance expression in 297 
NPR. Valles et al.
25
 pointed out that DEF potentially inhibited not only esterases but also 298 
microsomal oxidases in German cockroach Blattella gennanica (L.), although this was 299 
never reported for mites. This might be a potential reason that, although complex I 300 
inhibitors had been widely used for the mite control, development of serious resistance 301 
against cyenopyrafen has never been reported in field T. urticae population in Japan for 302 
≈4 years after the commercialization. 303 
Another point of our findings is the significant maternal effects in the resistance 304 
levels toward pyridaben in eggs derived from the reciprocal crosses between NPR and 305 
NS. Complete maternal inheritance of acaricide resistance has been reported in the 306 
bifenazate-resistant Belgian population.
18
 The maternal effects are caused by mutations 307 
in the mitochondrial cytochrome b, and the mutations confer cross-resistance toward 308 
acequinocyl.
26
 However, although the maternal effect was supported in adult females in 309 
bifenazate resistance, the maternal effects in pyridaben resistance appeared in eggs but 310 
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disappeared in adult females. Moreover, synergistic tests indicate that the detoxification 311 
by cytochrome P450 is the major mechanism conferring pyridaben resistance. Therefore, 312 
the mechanisms of such the age-dependent maternal effects remain still unclear. 313 
Partial maternal effects on resistance were reported in the complex I inhibitors 314 
(pyridaben and fenpyroximate) by Stumpf and Nauen.
10
 However, the maternal effect 315 
was not clearly supported and was not documented in subsequent studies, where maternal 316 
inheritance was mainly evaluated in F1 females.
7,9,27
 Because ND1 and ND5 genes of 317 
mitochondrial complex I subunits are encoded on mitochondrial DNA, if target-site 318 
resistance would be in place most likely only ND1 and/or ND5 subunits are involved. 319 
However, given that the maternal effects in eggs can be explained by such target-site 320 
resistance, there are no reasons that such target site insensitivity cannot function as an 321 
alternative resistance mechanism when the metabolism was inhibited by chemicals. 322 
Additionally, no evidence has been reported in the complex I inhibitor resistance-related 323 
mutation of ND1 and ND5.
2
 It is worth investigating, if expression of the cytochrome 324 
P450 gene involved in pyridaben resistance is low in eggs like as CYP392E10, what 325 
factors can be conferring pyridaben resistance in eggs. Further studies including analyses 326 
of target-site genetic modification in mitochondrial DNA and detoxification enzyme 327 
activities in eggs will be required to elucidate mechanisms of the age-dependent maternal 328 
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Figure legends 419 
 420 
Figure 1.  Concentration–mortality lines for cyenopyrafen (a) and pyridaben (b) in eggs 421 
of susceptible (NS) and resistant (NCR, NPR) strains and in F1 eggs from 422 
reciprocal crosses between the susceptible and resistant strains, respectively; 423 
open and solid triangles represent NCR and NS strains, respectively. Open 424 
and solid circles represent F1 eggs from R (♀) × S (♂) and S × R crosses, 425 
respectively. Data from NPR are not shown because its LC50 was too high to 426 
be determined (>10000 mg L
−1
; see Table 1). 427 
 428 
Figure 2.  Concentration-mortality lines for cyenopyrafen (a) and pyridaben (b) in adult 429 
females of NS and resistant (NCR, NPR) strains and in F1 adult females from 430 
reciprocal crosses between the susceptible and resistant strains. Open and 431 
solid triangles represent NCR and NS strains, respectively; open and solid 432 
circles represent F1 adult females from R (♀) × S (♂) and S × R crosses, 433 
respectively. Data from NPR are not shown because its LC50 was too high to 434 
be determined (>10000 mg L
−1

































































































Table 1 Logarithmic dose-probit mortality regression line data against cyenopyrafen 446 
(Cye) and pyridaben (Pyr) expressed as LC50, slope, and resistance factor (RF) in 447 
acaricide-susceptible strain (NS), field collected population (NO), and strains selected by 448 
pyridaben (NPR) and cyenopyrafen (NCR) 449 
Strains Acaricides 
Developmenta





limits of LC50 
values 
Regression lines RF 
NS Cye Egg 0.25  0.24–0.26 Y = 6.40 X + 8.84 1  
  
Adult female 2.42  2.08–2.83 Y = 3.38 X + 3.70 1  
 
Pyr Egg 0.76  0.717–0.80 Y = 3.8 X + 5.46 1  
    Adult female 3.87  3.29–4.57 Y = 3.07 X + 3.19 1  
NO Cye Egg 35.00  29.27–43.19 Y = 1.31 X + 2.98 140  
  
Adult female 59.34  51.60–69.58 Y = 2.60 X + 0.40 24.52  
 
Pyr Egg 0.42  0.38–0.46 Y = 1.90 X + 5.71 0.55  
    Adult female 2.24  0.00–37.64 Y = 0.21 X + 4.93 0.58  
NCR Cye Egg 103.68  94.01–114.47 Y = 1.78 X − 4.75 414.72  
  
Adult female 1502.82  1323.69–1707.14 Y = 3.07 X + 1.41 621  
 
Pyr Egg 1454.98  947.72–2222.77 Y = 0.40 X + 3.74 1914.45  
  
Adult female >10000 — Y = 0.24 X + 3.66 >2583.98  
NPR Cye Egg 74.16  68.59–80.02 Y = 2.86 X − 0.36 296.64  
    Adult female 430.99  347.22–547.35 Y = 1.91 X − 0.03 178.10  
  Pyr Egg >10000 — — >13157.89  





Table 2 Logarithmic dose-probit mortality regression line data against cyenopyrafen 452 
(Cye) and pyridaben (Pyr) expressed as LC50, slope, and degree of dominance of 453 
resistance (D) in F1 adult females produced by reciprocal crosses between NS and NCR, 454 
and between NS and NPR strains 455 
Acaricides 
Crosses 
(♀ × ♂) 
LC50 values for F1 
females (mg/L) 
95% fiducial limits 
of LC50 values 
Regression lines D 
Cye NCR × NS 271.28  249.02–294.60 Y = 5.24 X − 7.74 0.47 
 
NS × NCR 299.47  277.37–321.38 Y = 4.76 X − 6.78 0.50 
Pyr NPR × NS >10000 8610.80–>10000 Y = 1.45 X − 0.95 — 




Table 3 Synergistic effects of PBO, IBP, TPP, and DEM on adult females of NS, NCR, 457 






95% fiducial limits  




NS Cye 2.42  2.085–2.83 Y = 3.38 X + 3.70 1  
 
+ PBO 2.08  1.49–3.27 Y = 1.14 X + 4.64 1.16  
 
+ IBP 12.12  10.20–14.65 Y = 2.58 X + 2.21 0.20  
 
+ TPP 21.70  19.0–25.1 Y = 3.20 X + 0.64 0.11  
 
+ DEM 1.39  1.17–1.64 Y = 3.09 X + 4.56 1.74  
NCR Cye 1502.82  1323.69–1707.14 Y = 3.07 X − 4.75 1  
 
+ PBO 18.74  15.46 – 22.48 Y = 2.25 X +2.14 80.19 
 
+ IBP 734.15  602.09–869.34 Y = 2.16 X − 1.18 2.05  
 
+ TPP 22.01  16.61–28.21 Y = 1.43 X + 3.07 68.28  
  + DEM 551.25  464.71–662.90 Y = 2.41 X − 1.16 2.73  
NS Pyr 3.87  3.29–4.57 Y = 3.07 X + 3.19 1  
 
+ PBO 0.09  0.07–0.12 Y = 1.49 X + 6.56 43  
 
+ IBP 2.79  2.05–4.07 Y = 1.65 X + 4.27 1.39  
 
+ TPP 1.36  0.97–2.00 Y = 1.28 X + 4.83 2.85  
  + DEM 3.04  2.33–4.50 Y = 2.08 X + 4.00 1.27  
NPR Pyr >10000  — — 1  
 
+ PBO 73.24  53.31–109.73 Y = 1.37 X + 2.44 >136.54  
 
+ IBP >10000  — — 1.00  
 
+ TPP >10000  — — 1.00  
  + DEM >10000  — — 1.00  
 459 
 460 
